Antineoplastic Agents

Antineoplastic Agents Companies (23)

Antineoplastic Agents Products (139)

  • Product CARBOPLATIN

    Dosage Strengths Available: 150 mg/15 ml, 450 mg/45 ml
    Dosage Form: Ready-to-infuse vials·  Packaging: Single-use vial

    Packing Options: Glass vials with flip-off seals and tear-off aluminum caps, available in single vial mono, or 10's vials pack

    Customizat...
  • Product Pembrolizumab

    Pembrolizumab is an anti-PD-1 mAb with the broadest approved indication portfolio globally. Spanning NSCLC first-line to MSI-H/TMB-H pan-tumor indications, it represents the absolute benchmark in immuno-oncology with an exceptionally high market ceiling.
  • Product Pembrolizumab 100 mg/4 ml

    Description: Sterile injectable formulation of pembrolizumab, a monoclonal antibody used in immunotherapy. It enhances the body’s immune response against tumor cells by targeting immune checkpoint pathways. Commonly used in the treatment of various cancers, including melanoma, lung cancer, and other advan...
  • Product Pemetrexed disodium

    Carelife offers a wide range of products which includes Clindamycin Hydrochloride, Phosphate, Palmitate Hydrochloride. 

     We also offer:  

    Iron sucrose
    Ferric carboxymaltose
    Pemetrexed disodium
    Granisetron HCl
    Mitoxantrone HCl...
  • Product Leuprorelin Acetate

    Treatment of endometriosis, uterine fibroids, prostate cancer, and central precocious puberty.

  • Product Naprod Product List

    General LyophilizedGeneral Liquid
    Onco Liquid
    Onco lyophilized
    Onco OSD
  • Product Neutromax 30 M I.U./ 48 M I.U.

    Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.
    Biosidus Filgrastim product is av...
  • Product Oxaliplatin SEDICO vials

    Treat certain cancers, especially colorectal (colon and rectal) cancer.
  • Product Flupentixol Dihydrochloride BP/EP

    Flupentixol Dihydrochloride is an antipsychotic medication belonging to the thioxanthene class. It is primarily used to treat schizophrenia and other mental health disorders, including depression.

    Mechanism of Action:

    Alters the balance of neurotransmitters in the brain, parti...
  • Product Abiraterone Acetate

    Kekule Pharma offers a wide range of Active Pharmaceutical Ingredients which includes Abiraterone Acetate. It belongs to AntiNeoplastics  Therapy category. Contact us for more information.
  • Product Bupivacaine Hydrochloride Injection

    Bupivacaine Hydrochloride Injection is a sterile, preservative-free injectable preparation containing Bupivacaine Hydrochloride. It is a long-acting local anaesthetic used to produce regional or local anaesthesia by temporarily blocking the transmission of nerve impulses from the targeted area. The injecti...
  • Product Erlotinib

    Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r...
  • Product Abemaciclib

    CAS NO.1231929-97-7
  • Product Finished formulation for General products and Oncology products

    Finished formulation for General products and Oncology products 

    Formulations available in 
    -- Tablets 
    -- Capsules 
    -- Dry powder for suspension 


    Products packed in 
    -- Blister pack
    -- Drum pack 
    -- Bottle Pack
    -- Sachet 

  • Product Trabectedin

    Purity:99% 100g;1kg;10kg
  • Product 10-Deacetylbaccatin III

    Intermediate for Cabazitaxel,Docetaxel, Paclitaxel
  • Product Enzalutamide Soft Capsules

    Suitable for metastatic resistance to prostate cancer (CRPC). After the failure of androgen deprivation of therapy (ADT), Enzalutamide can delay the progress of the disease by inhibiting the inhibitors of therogen receptor signaling pathway and improve the quality of life of patients.
  • Product Ruxolitinib

    Therapeutic Area: Oncology Status: Early

Upcoming Events

  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
  • PMEC India 2026

    IEML, Greater Noida, Delhi
    24 Nov 2026 - 26 Nov 2026
  • Pharmapack Europe 2027

    Paris Expo, Porte de Versailles - Hall 4 | Paris, France
    27 Jan 2027 - 28 Jan 2027

Pharmaceutical Industry Webinars